HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafael Molina Selected Research

big gastrin

7/2021Tumour markers with clinically controlled cut-offs for suspected cancer.
9/2020A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.
2/2016Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.
1/2009Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology.
5/2005Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
7/2004ProGRP: a new biomarker for small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafael Molina Research Topics

Disease

35Neoplasms (Cancer)
01/2022 - 05/2003
9Lung Neoplasms (Lung Cancer)
02/2016 - 01/2004
8Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2004
8Colorectal Neoplasms (Colorectal Cancer)
09/2014 - 05/2004
8Breast Neoplasms (Breast Cancer)
01/2012 - 01/2003
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 01/2004
6Adenocarcinoma
06/2012 - 05/2005
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2021 - 05/2003
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2020 - 01/2004
5Renal Insufficiency (Renal Failure)
04/2012 - 01/2004
4Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2017 - 01/2004
4Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 01/2008
3Pleural Effusion (Pleural Effusions)
09/2019 - 09/2004
3Carcinoma (Carcinomatosis)
10/2018 - 05/2003
3Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2018 - 05/2003
3Ascites
10/2015 - 09/2004
3Liver Diseases (Liver Disease)
04/2012 - 01/2008
2Neoplasm Metastasis (Metastasis)
08/2012 - 04/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
06/2012 - 01/2008
2Jaundice (Icterus)
06/2012 - 04/2012
2Melanoma (Melanoma, Malignant)
01/2007 - 01/2002
1Infections
01/2021
1Cardiogenic Shock
02/2020
1Vasculitis (Vasculitides)
10/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2018
1Squamous Cell Carcinoma of Head and Neck
04/2018
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2018
1Thyroid Neoplasms (Thyroid Cancer)
03/2017
1Malignant Pleural Effusion
01/2017
1Chronic Renal Insufficiency
01/2015
1Adenoma (Adenomas)
12/2013
1Hypoxia (Hypoxemia)
08/2012
1Primitive Neuroectodermal Tumors (PNET)
08/2012
1Wasting Syndrome (Wasting Disease)
04/2012
1Hemolysis
04/2012
1Liver Cirrhosis (Hepatic Cirrhosis)
04/2012
1Prostatitis
04/2012
1Inflammation (Inflammations)
10/2010

Drug/Important Bio-Agent (IBA)

20Tumor Biomarkers (Tumor Markers)IBA
02/2020 - 01/2002
10AntigensIBA
07/2021 - 01/2007
10Carcinoembryonic AntigenIBA
07/2021 - 05/2003
7Prostate-Specific Antigen (Semenogelase)IBA
07/2021 - 06/2004
7pro-gastrin-releasing peptide (31-98)IBA
09/2020 - 01/2004
7Biomarkers (Surrogate Marker)IBA
10/2018 - 07/2004
6Peptides (Polypeptides)IBA
07/2021 - 07/2004
6big gastrinIBA
07/2021 - 07/2004
4CarbohydratesIBA
07/2021 - 07/2010
4Keratin-19 (Keratin 19)IBA
02/2016 - 09/2004
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2015 - 06/2010
4antigen CYFRA21.1IBA
01/2009 - 05/2005
3Phosphopyruvate Hydratase (Enolase)IBA
07/2021 - 04/2012
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2021 - 12/2008
3MucinsIBA
10/2018 - 11/2005
3Trastuzumab (Herceptin)FDA Link
12/2008 - 12/2003
2Coloring Agents (Dyes)IBA
01/2022 - 11/2021
2Hemoglobins (Hemoglobin)IBA
09/2014 - 12/2013
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
04/2012 - 01/2008
2Oncogene Proteins (Oncogene Protein)IBA
01/2012 - 06/2010
2Proteins (Proteins, Gene)FDA Link
11/2011 - 01/2007
2CreatinineIBA
02/2011 - 01/2004
2Estrogen ReceptorsIBA
07/2010 - 06/2010
2Estrogens (Estrogen)FDA Link
12/2008 - 11/2005
2Hormones (Hormone)IBA
12/2008 - 11/2005
2Progesterone Receptors (Progesterone Receptor)IBA
12/2008 - 11/2005
2Plasminogen Activator Inhibitor 1IBA
12/2008 - 11/2005
2Plasminogen Activators (Plasminogen Activator)IBA
12/2008 - 11/2005
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2008 - 11/2005
2MicronutrientsIBA
03/2007 - 05/2004
1N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA
01/2022
1GuanosineIBA
01/2021
1NucleosidesIBA
01/2021
1Adenosine (Adenocard)FDA LinkGeneric
01/2021
1Adenosine DeaminaseIBA
09/2019
1C-Reactive ProteinIBA
09/2019
1AutoantibodiesIBA
10/2018
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2018
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2018
1squamous cell carcinoma-related antigenIBA
04/2018
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2017
1Tyrosine Kinase InhibitorsIBA
03/2017
1Folate Receptor 1IBA
01/2016
1Kallikreins (Kallikrein)IBA
01/2016
1Pharmaceutical PreparationsIBA
04/2015
1AntibodiesIBA
09/2013
1Complement System Proteins (Complement)IBA
06/2013
1Lipocalin-2IBA
05/2013
1LigandsIBA
08/2012
1Sunitinib (Sutent)FDA Link
08/2012
1BilirubinIBA
06/2012
1tumor-associated antigen 72IBA
04/2012
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
04/2012
1Chromogranin AIBA
02/2011
1Interleukin-6 (Interleukin 6)IBA
10/2010
1human ERBB2 proteinIBA
06/2010
1Mucin-1 (CA 15-3 Antigen)IBA
06/2010

Therapy/Procedure

7Therapeutics
09/2013 - 01/2003
2Drug Therapy (Chemotherapy)
09/2020 - 04/2015
2Mediterranean Diet
03/2007 - 05/2004
1Length of Stay
02/2020
1Prostatectomy (Retropubic Prostatectomy)
10/2010